Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Neurex's blood pressure treatment up for FDA advisory panel review in June

April 29, 1997

NOS inhibitors disclosed by Searle

April 29, 1997

FDA approves new labeling for Bristol-Myers Squibb's Pravachol

April 29, 1997

Angiotensin II antagonist effective for progression of diabetic nephropathy

April 29, 1997

Xoma and Pfizer discontinue U.S. phase III trial of E5

April 28, 1997

Potent TNF inhibitor described by Celgene

April 28, 1997

Novel marine antioxidant described by UNC researchers

April 25, 1997

New alpha1-adrenoceptor antagonist evaluated

April 25, 1997

Endothelin antagonists disclosed by BASF

April 24, 1997

Comparison of aspirin and pentoxifylline for claudication

April 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...